Novel anti-inflammatory mesothelial signaling to the spleen
向脾脏发出新型抗炎间皮信号
基本信息
- 批准号:10092954
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-CholinergicsAnti-Inflammatory AgentsBiologicalBloodBreedingCell CommunicationCellsCollagenCommunicationComplexCytoplasmDataDevelopmentDiseaseDistalElementsEndotoxinsFibrosisFlow CytometryFunctional disorderGenesGoalsHomologous GeneHospitalizationHourImmuneImmune responseIncidenceInfectionInflammationInflammatoryInflammatory ResponseInstitutionKnock-outLaboratoriesLifeLiverLoxP-flanked alleleLungMediatingMesothelial CellMesotheliumMusNerve PlexusNeuronsNicotinic ReceptorsOperative Surgical ProceduresOrganOrganellesPathogenesisPathway interactionsPatientsPeritoneumPhenotypePhysiologicalPositioning AttributeRattusReflex actionReportingReticuloendothelial SystemSepsisShockSignal PathwaySignal TransductionSiteSourceSpleenStimulusSurgical incisionsSystemTNF geneTestingTissuesWT1 genealpha-bungarotoxin receptorcell typecholinergiccostcytokineileummortalitynerve supplynovelnovel therapeutic interventionpromoterrelating to nervous systemresponsesplenic capsulesystemic inflammatory response
项目摘要
Project Summary/Abstract
Sepsis is a complex lethal condition defined as “life- threatening organ dysfunction caused by a dysregulated
host response to infection”. In the U.S, sepsis is related to ~1 million hospitalizations annually, and the incidence
of sepsis continues to rise. The mortality rate from in patients with sepsis remains unacceptably high. Novel data
from our laboratory recently demonstrated that simply moving the spleen to midline and then returning it to its
original position causes development of splenic capsular fibrosis and a pro-inflammatory shift in the immune cell
phenotype of the spleen. While similar findings have been reported in mice, it remains unclear how these
maneuvers promote a pro-inflammatory phenotype. Our novel data indicate that specialized mesothelial cells
that form connections to the splenic capsule may transmit tonic anti-inflammatory signals to spleen via
cholinergic signaling through alpha 7 nicotinic receptors. In addition to markers of cholinergic signaling, these
mesothelial cells strongly express neuronal markers and display neuronal-like organelles within their cytoplasm.
As the connections themselves are made of collagen lined with mesothelial cells, splenic capsular fibrosis
following disruption of these connections may represent a physiological response to try to re-establish
mesothelial cell to cell signaling. The primary goal of this proposal is to determine whether cholinergic signaling
through specialized mesothelial cells does indeed transmit tonic anti-inflammatory signals to the splenic capsule
and whether disruption of this signaling has a functional response, exacerbating the systemic inflammatory
response to endotoxin. As such, Aim 1 will test whether `Surgical disruption of mesothelial signaling to the splenic
capsule results in a prolonged anti-inflammatory profile and exacerbated inflammatory response to endotoxin'.
We will access the spleen in rats via a flank incision and clear the spleen of mesothelial connections without
interfering with the spleen. Baseline immune profiles (flow cytometry/cytokine analysis) and the physiological
response to experimental inflammatory shock (endotoxin) in anesthetized disrupted and sham surgical rats will
be determined 24 hours, 21 days and 3 months following surgical disruption of mesothelial connections to the
spleen Aim 2 will test whether `Non-neuronal cholinergic signaling between mesothelial cells mediates a tonic
anti-inflammatory response in the spleen'. Global deletion of α7nAChR in mice results in a pro-inflammatory
splenic phenotype however, the cell type(s) mediating this effect remain unclear. We will use Wilms tumor 1
homolog gene promoter Cre and Chrna7tm1 floxed mice to `knockout' α7nAChR specifically in mesothelial cells.
We predict that loss of the α7nAChR specifically in mesothelial cells will promote a pro-inflammatory phenotype
in the spleen. If our hypothesis is correct, neuronal like signaling between distal sites through mesothelial cells
would represent a previously unrecognized pathway of biological communication and would likely have a major
impact not only on our understanding of the factors that regulate systemic immune responses in sepsis, but also
idiopathic fibrosis of other organs involving the mesothelium.
项目概要/摘要
败血症是一种复杂的致命性疾病,定义为“由失调引起的危及生命的器官功能障碍”
宿主对感染的反应”。在美国,败血症每年与约 100 万人住院有关,而且发病率也很高。
脓毒症患者的死亡率仍然高得令人无法接受。
我们实验室最近证明,只需将脾脏移至中线,然后将其返回到原来的位置
原始位置导致脾被膜纤维化的发展和免疫细胞的促炎性转变
虽然在小鼠中也有类似的发现,但目前尚不清楚这些结果是如何发生的。
我们的新数据表明,特殊的间皮细胞会促进促炎表型。
与脾被膜形成连接的细胞可能通过以下途径向脾脏传递补强抗炎信号:
通过 α7 烟碱受体的胆碱能信号传导 除了胆碱能信号传导的标记物之外,这些。
间皮细胞强烈表达神经元标记,并在其细胞质内展示神经元样细胞器。
由于连接本身是由衬有间皮细胞的胶原蛋白构成的,因此脾被膜纤维化
这些连接中断后可能代表尝试重新建立的生理反应
该提案的主要目标是确定间皮细胞间信号传导是否存在。
通过专门的间皮细胞确实将强效抗炎信号传递到脾被膜
以及该信号传导的破坏是否会产生功能性反应,从而加剧全身炎症
因此,目标 1 将测试“脾脏间皮信号传导是否受到手术破坏”。
胶囊导致延长的抗炎作用并加剧对内毒素的炎症反应。
我们将通过侧腹切口进入大鼠的脾脏,并清除脾脏的间皮连接,而无需
干扰脾脏的基线免疫特征(流式细胞术/细胞因子分析)和生理学。
麻醉中断大鼠和假手术大鼠对实验性炎症休克(内毒素)的反应
手术中断间皮连接后 24 小时、21 天和 3 个月确定
脾脏目标 2 将测试“间皮细胞之间的非神经元胆碱能信号传导是否介导强直”
小鼠脾脏中 α7nAChR 的整体缺失导致促炎反应。
然而,介导这种效应的细胞类型仍不清楚,我们将使用肾母细胞瘤 1。
同源基因启动子 Cre 和 Chrna7tm1 使小鼠在间皮细胞中“敲除”α7nAChR。
我们预测间皮细胞中 α7nAChR 的缺失将促进促炎表型
如果我们的假设是正确的,远端部位之间的神经样信号传导将通过间皮细胞进行。
将代表一种以前未被认识的生物通讯途径,并且可能具有重大意义
不仅影响我们对脓毒症全身免疫反应调节因素的理解,而且
涉及间皮的其他器官的特发性纤维化。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ALKALI SUPPLEMENTATION AS A THERAPEUTIC IN CHRONIC KIDNEY DISEASE: WHAT MEDIATES PROTECTION?
- DOI:10.1152/ajprenal.00343.2020
- 发表时间:2020-11
- 期刊:
- 影响因子:0
- 作者:Elinor C. Mannon;P. O’Connor
- 通讯作者:Elinor C. Mannon;P. O’Connor
New mechanisms for the kidney-protective effect of alkali in chronic kidney disease.
碱对慢性肾脏病的肾脏保护作用的新机制。
- DOI:10.1042/cs20220395
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:O'Connor,PaulM;Mannon,ElinorC
- 通讯作者:Mannon,ElinorC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Michael O'Connor其他文献
Paul Michael O'Connor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Michael O'Connor', 18)}}的其他基金
DAMPs, vasa recta pericytes, pressure-natriuresis and hypertension
DAMP、直肠血管周细胞、压力尿钠和高血压
- 批准号:
10094232 - 财政年份:2017
- 资助金额:
$ 23.1万 - 项目类别:
Role of HV1 in development of salt-sensitive hypertension and renal injury
HV1 在盐敏感性高血压和肾损伤发展中的作用
- 批准号:
9248327 - 财政年份:2014
- 资助金额:
$ 23.1万 - 项目类别:
Role of HV1 in development of salt-sensitive hypertension and renal injury
HV1 在盐敏感性高血压和肾损伤发展中的作用
- 批准号:
8758494 - 财政年份:2014
- 资助金额:
$ 23.1万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于片段的P2Y14受体拮抗剂的设计、合成和抗炎活性研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
两种民族药用植物中黄酮类ILCreg诱导剂的发现及其抗炎性肠病机制探究
- 批准号:81960777
- 批准年份:2019
- 资助金额:34 万元
- 项目类别:地区科学基金项目
相似海外基金
Vagal control of tissue SUMOylation as a novel anti-inflammatory target in IBD
迷走神经控制组织 SUMO 化作为 IBD 的新型抗炎靶点
- 批准号:
10372373 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Investigating the vagal gut-brain circuit regulating hippocampal neurochemistry and neuroinflammation
研究调节海马神经化学和神经炎症的迷走神经肠脑回路
- 批准号:
10534301 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
The Role of the Aging Brain-Heart-Immune Axis in Postoperative Delirium
老化的脑-心-免疫轴在术后谵妄中的作用
- 批准号:
10517672 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别: